Bioinformatics Markets

Abstract

The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications believes that many of the segments of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years. This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for significant future growth. Each segment is accompanied by analysis and forecasts by product type and application.

This analysis surveys the bioinformatics market and the latest information regarding emerging new products and industry trends. The study will quantify and qualify the bioinformatics market segments as an area of research, product development and investment. Forecasts of the bioinformatics market and an analysis of products in the worldwide information-processing market will provide a basis for understanding the significance of past developments and future possibilities within this market category.

• Identify viable technology drivers through a comprehensive look at various platform technologies for segments of the bioinformatics market.
• Impart a complete understanding of the chief bioinformatics tools and their predictive, screening, prognostic, monitoring, pharmacogenomic and product value, from basic principles to application.
• Distinguish feasible market opportunities via identifying high-growth applications in different bioinformatics areas, with a focus on the biggest and fastest expanding markets for diagnosis and treatment of diseases.
• Focus on global industry development through an in-depth analysis of the major world markets for bioinformatics, including forecasts for growth.
• Present market figures regarding the current value of the bioinformatics market, projections and growth rates. The source of this information is the most current data derived from the global diagnostic industry.

Methodology

The author of this report is a Ph.D. in biochemistry from the University of Minnesota, with many decades of experience in scientific writing and as a medical industry analyst. He has been a senior director of several large regional and national healthcare laboratories. The senior editor is a Ph.D. in physiology with a focus on computational physiology from the University of Toronto in Canada, with postdoctoral training and experience in cell and systems biology from the University of Toronto. The editor is a Ph.D. in biomedical sciences with a focus in microbiology from Meharry Medical College in Nashville, TN, with postdoctoral training and experience in molecular and cell biology as well as computational analysis obtained at the University of Pittsburgh, the National Institutes of Health and, most recently, at the Walter Reed Army Institute of Research.

Company-specific information is obtained mainly from industry trade publications, academic journals, news and research articles, press releases and corporate websites, as well as annual reports for publicly-held firms. Additionally, sources of information include the non-governmental organizations (NGOs) such as the World Health Organization (WHO) and governmental entities like the U.S. Department of Health and Human Services (HHS) and U.S. federal agencies such as National Institutes of Health (NIH), Food and Drug Adminstration (FDA) and the Centers of Disease Control and Prevention (CDC). Where possible and practicable, the most recent data available have been used.

Some of the statistical information was taken from Biotechnology Associates' databases and from TriMark' s private data stores. The information in this study was obtained from sources that we believe to be reliable, but we do not guarantee the accuracy, adequacy or completeness of any information or omission or for the results obtained by the use of such information. Key information from the business literature was used as a basis to conduct dialogue with and obtain expert opinion from market professionals regarding commercial potential and market sizes. Senior managers from major company players were interviewed for part of the information in this report.

TriMark collects information from hundreds of Database Tables and many comprehensive multi-client research projects, as well as Sector Snapshots that we publish annually. We extract relevant data and analytics from TriMark' s research as part of this data collection.

TriMark uses research publications, journals, magazines, newspapers, newsletters, industry reports, investment research reports, trade and industry association reports, government-affiliated trade releases and other published information as part of its secondary research materials. The information is then analyzed and translated by the Industry Research Group into a TriMark study. The Editorial Group reviews the complete package with product and market forecasts, critical industry trends, threats and opportunities, competitive strategies and market share determinations.